A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years

Vishal Sharma, Susanne Coleman, Jane Nixon, Linda Sharples, Julian Hamilton-Shield, Harry Rutter, Maria Bryant

Research output: Contribution to journalArticle

Abstract

Summary Evidence for the health impact of obesity has largely focussed on adults. We estimated the population prevalence and prevalence ratio of obesity-associated comorbidities in children and adolescents aged 5 to 18 years. Five databases were searched from inception to 14 January 2018. Population-based observational studies reporting comorbidity prevalence by weight category (healthy weight/overweight/obese) in children and adolescents aged 5 to 18 years from any country were eligible. Comorbidity prevalence, stratified by weight category, was extracted and prevalence ratios (relative to healthy weight) estimated using random effects meta-analyses. Of 9183 abstracts, 52 eligible studies (1 553 683 participants) reported prevalence of eight comorbidities or risk markers including diabetes and nonalcoholic fatty liver disease (NAFLD). Evidence for psychological comorbidities was lacking. Meta-analyses suggested prevalence ratio for prediabetes (fasting glucose ≥ 100 mg/dL) for those with obesity relative to those of a healthy weight was 1.4 (95% confidence interval [CI], 1.2-1.6) and for NAFLD 26.1 (9.4-72.3). In the general population, children and adolescents with overweight/obesity have a higher prevalence of comorbidities relative to those of a healthy weight. This review provides clinicians with information when assessing children and researchers a foundation upon which to build a comprehensive dataset to understand the health consequences of childhood obesity.
Original languageEnglish
Pages (from-to)1341-1349
Number of pages9
JournalObesity Reviews
Volume20
Issue number10
Early online date24 Jul 2019
DOIs
Publication statusPublished - 1 Oct 2019

Keywords

  • childhood obesity
  • comorbidities
  • population prevalence
  • systematic review

Cite this

A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years. / Sharma, Vishal; Coleman, Susanne; Nixon, Jane; Sharples, Linda; Hamilton-Shield, Julian; Rutter, Harry; Bryant, Maria.

In: Obesity Reviews, Vol. 20, No. 10, 01.10.2019, p. 1341-1349.

Research output: Contribution to journalArticle

Sharma, Vishal ; Coleman, Susanne ; Nixon, Jane ; Sharples, Linda ; Hamilton-Shield, Julian ; Rutter, Harry ; Bryant, Maria. / A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years. In: Obesity Reviews. 2019 ; Vol. 20, No. 10. pp. 1341-1349.
@article{ccf74e0b3e654ef1a536d5b5f882ee26,
title = "A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years",
abstract = "Summary Evidence for the health impact of obesity has largely focussed on adults. We estimated the population prevalence and prevalence ratio of obesity-associated comorbidities in children and adolescents aged 5 to 18 years. Five databases were searched from inception to 14 January 2018. Population-based observational studies reporting comorbidity prevalence by weight category (healthy weight/overweight/obese) in children and adolescents aged 5 to 18 years from any country were eligible. Comorbidity prevalence, stratified by weight category, was extracted and prevalence ratios (relative to healthy weight) estimated using random effects meta-analyses. Of 9183 abstracts, 52 eligible studies (1 553 683 participants) reported prevalence of eight comorbidities or risk markers including diabetes and nonalcoholic fatty liver disease (NAFLD). Evidence for psychological comorbidities was lacking. Meta-analyses suggested prevalence ratio for prediabetes (fasting glucose ≥ 100 mg/dL) for those with obesity relative to those of a healthy weight was 1.4 (95{\%} confidence interval [CI], 1.2-1.6) and for NAFLD 26.1 (9.4-72.3). In the general population, children and adolescents with overweight/obesity have a higher prevalence of comorbidities relative to those of a healthy weight. This review provides clinicians with information when assessing children and researchers a foundation upon which to build a comprehensive dataset to understand the health consequences of childhood obesity.",
keywords = "childhood obesity, comorbidities, population prevalence, systematic review",
author = "Vishal Sharma and Susanne Coleman and Jane Nixon and Linda Sharples and Julian Hamilton-Shield and Harry Rutter and Maria Bryant",
note = "doi: 10.1111/obr.12904",
year = "2019",
month = "10",
day = "1",
doi = "10.1111/obr.12904",
language = "English",
volume = "20",
pages = "1341--1349",
journal = "Obesity Reviews",
issn = "1467-7881",
publisher = "John Wiley & Sons",
number = "10",

}

TY - JOUR

T1 - A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years

AU - Sharma, Vishal

AU - Coleman, Susanne

AU - Nixon, Jane

AU - Sharples, Linda

AU - Hamilton-Shield, Julian

AU - Rutter, Harry

AU - Bryant, Maria

N1 - doi: 10.1111/obr.12904

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Summary Evidence for the health impact of obesity has largely focussed on adults. We estimated the population prevalence and prevalence ratio of obesity-associated comorbidities in children and adolescents aged 5 to 18 years. Five databases were searched from inception to 14 January 2018. Population-based observational studies reporting comorbidity prevalence by weight category (healthy weight/overweight/obese) in children and adolescents aged 5 to 18 years from any country were eligible. Comorbidity prevalence, stratified by weight category, was extracted and prevalence ratios (relative to healthy weight) estimated using random effects meta-analyses. Of 9183 abstracts, 52 eligible studies (1 553 683 participants) reported prevalence of eight comorbidities or risk markers including diabetes and nonalcoholic fatty liver disease (NAFLD). Evidence for psychological comorbidities was lacking. Meta-analyses suggested prevalence ratio for prediabetes (fasting glucose ≥ 100 mg/dL) for those with obesity relative to those of a healthy weight was 1.4 (95% confidence interval [CI], 1.2-1.6) and for NAFLD 26.1 (9.4-72.3). In the general population, children and adolescents with overweight/obesity have a higher prevalence of comorbidities relative to those of a healthy weight. This review provides clinicians with information when assessing children and researchers a foundation upon which to build a comprehensive dataset to understand the health consequences of childhood obesity.

AB - Summary Evidence for the health impact of obesity has largely focussed on adults. We estimated the population prevalence and prevalence ratio of obesity-associated comorbidities in children and adolescents aged 5 to 18 years. Five databases were searched from inception to 14 January 2018. Population-based observational studies reporting comorbidity prevalence by weight category (healthy weight/overweight/obese) in children and adolescents aged 5 to 18 years from any country were eligible. Comorbidity prevalence, stratified by weight category, was extracted and prevalence ratios (relative to healthy weight) estimated using random effects meta-analyses. Of 9183 abstracts, 52 eligible studies (1 553 683 participants) reported prevalence of eight comorbidities or risk markers including diabetes and nonalcoholic fatty liver disease (NAFLD). Evidence for psychological comorbidities was lacking. Meta-analyses suggested prevalence ratio for prediabetes (fasting glucose ≥ 100 mg/dL) for those with obesity relative to those of a healthy weight was 1.4 (95% confidence interval [CI], 1.2-1.6) and for NAFLD 26.1 (9.4-72.3). In the general population, children and adolescents with overweight/obesity have a higher prevalence of comorbidities relative to those of a healthy weight. This review provides clinicians with information when assessing children and researchers a foundation upon which to build a comprehensive dataset to understand the health consequences of childhood obesity.

KW - childhood obesity

KW - comorbidities

KW - population prevalence

KW - systematic review

U2 - 10.1111/obr.12904

DO - 10.1111/obr.12904

M3 - Article

VL - 20

SP - 1341

EP - 1349

JO - Obesity Reviews

JF - Obesity Reviews

SN - 1467-7881

IS - 10

ER -